Security key
19188J409
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)
CUSIP: 19188J409
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 1,112,121
- Total 13F value
- $1,167,387
- Share change
- +387,381
- SEC-reported price per share
- $1.05
- Number of holders
- 26
- Value change
- +$407,761
- Number of buys
- 8
- Number of sells
- 11
- Shares outstanding
- 19,232,824
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
26
Top holders
10
COCP full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Cocrystal Pharma, Inc. SEC filings
Cocrystal Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 19188J409
Recent filing periods:
Ownership snapshot
Top reported holders of COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
VANGUARD CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
31 Mar 2026
13F
Lead comparable stake: 1.2%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 1.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
VANGUARD CAPITAL MANAGEMENT LLC
1.2%
RENAISSANCE TECHNOLOGIES LLC
0.64%
GEODE CAPITAL MANAGEMENT, LLC
0.47%
BlackRock, Inc.
0.38%
T3 Companies, LLC
0.27%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
1.2%
|
$242,371
239,971 shares
|
— | 31 Mar 2026 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.64%
|
$125,167
123,928 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.47%
|
$91,147
90,231 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
0.38%
|
$74,483
73,746 shares
|
— | 31 Mar 2026 |
| T3 Companies, LLC |
13F
Company
|
0.27%
|
$52,015
51,500 shares
|
— | 31 Mar 2026 |
| XTX Topco Ltd |
13F
Company
|
0.19%
|
$36,391
36,031 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
26
Shares
1,112,121
Rows available
26
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
25
Q2 2026 holders
26
Holder diff
1
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend